Junlong Hu

858 total citations · 2 hit papers
22 papers, 587 citations indexed

About

Junlong Hu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Junlong Hu has authored 22 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Junlong Hu's work include Circular RNAs in diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and MicroRNA in disease regulation (5 papers). Junlong Hu is often cited by papers focused on Circular RNAs in diseases (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and MicroRNA in disease regulation (5 papers). Junlong Hu collaborates with scholars based in China, Sweden and Netherlands. Junlong Hu's co-authors include Junjie Sun, Zhenwei Ge, Baocai Wang, Xiliang Zhu, Xiaozhong Li, Zhenjiang Bai, Yanhong Li, Jing Xu, Guoping Lü and Min Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and BMJ.

In The Last Decade

Junlong Hu

19 papers receiving 580 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human umbilical cord blood–derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice

2020 267 citations Baocai Wang, Xiliang Zhu et al. Cell Biology and Toxicology profile →
Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study

2024 91 citations Junlong Hu, Jing Xu et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junlong Hu China	9	358	267	158	78	71	22	587
Lindsey Tilling United Kingdom	7	356 1.0×	288 1.1×	38 0.2×	88 1.1×	78 1.1×	16	740
Zhipeng Yan China	15	271 0.8×	64 0.2×	83 0.5×	80 1.0×	55 0.8×	23	486
Shufu Chang China	10	381 1.1×	171 0.6×	61 0.4×	214 2.7×	183 2.6×	45	692
Haifeng Xu China	14	165 0.5×	154 0.6×	220 1.4×	83 1.1×	193 2.7×	44	678
Tao Jin China	10	212 0.6×	66 0.2×	265 1.7×	103 1.3×	99 1.4×	26	595
Yangyan He China	16	241 0.7×	151 0.6×	334 2.1×	111 1.4×	387 5.5×	53	791
Limin Lun China	14	209 0.6×	109 0.4×	47 0.3×	66 0.8×	68 1.0×	36	515
Giovanna Giannotti Italy	6	253 0.7×	140 0.5×	55 0.3×	176 2.3×	82 1.2×	10	587
Lu Yan China	13	134 0.4×	107 0.4×	261 1.7×	191 2.4×	68 1.0×	41	476

Countries citing papers authored by Junlong Hu

Since Specialization

Citations

This map shows the geographic impact of Junlong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlong Hu more than expected).

Fields of papers citing papers by Junlong Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlong Hu. The network helps show where Junlong Hu may publish in the future.

Co-authorship network of co-authors of Junlong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Junlong Hu. A scholar is included among the top collaborators of Junlong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlong Hu. Junlong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Yunpeng, Wei Zhang, Arnaldo Dimagli, et al.. (2024). Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ. 385. e075707–e075707. 11 indexed citations

Hu, Junlong, Jing Xu, Min Li, et al.. (2024). Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study. EClinicalMedicine. 68. 102409–102409. 91 indexed citations breakdown →

Xu, Jing, Jiao Chen, Min Li, et al.. (2024). Utility of plasma suPAR to identify AKI and sepsis associated AKI in critically ill children. iScience. 27(11). 111247–111247. 3 indexed citations

Hu, Junlong, et al.. (2024). Delayed sternal Mycobacterium tuberculosis infection after left ventricular assist device implantation: A case report. The International Journal of Artificial Organs. 47(3). 217–222.

Hu, Junlong, Xiaoling Wei, Li Gao, et al.. (2023). Determination of the optimal concentration and duration of C5aR antagonist application in an inflammatory model of human dental pulp cells. FEBS Open Bio. 13(3). 570–581. 1 indexed citations

Xue, Qing, Hao Liu, Junlong Hu, et al.. (2023). Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial. Frontiers in Cardiovascular Medicine. 10. 1103681–1103681. 2 indexed citations

Hu, Junlong, et al.. (2022). Circular RNAs expression profiles and bioinformatics analysis in bronchopulmonary dysplasia. Journal of Clinical Laboratory Analysis. 37(1). e24805–e24805. 3 indexed citations

Hu, Junlong, et al.. (2022). Prediction of urinary dickkopf-3 for AKI, sepsis-associated AKI, and PICU mortality in children. Pediatric Research. 93(6). 1651–1658. 10 indexed citations

Zhu, Yunpeng, Junlong Hu, Minlu Zhang, et al.. (2022). Influence of Baseline HbA1c and Antiplatelet Therapy on 1-Year Vein Graft Outcome. JACC Asia. 2(2). 197–206.

10.

Wu, Huanhuan, et al.. (2022). Stromal Vascular Fraction Promotes Viability of Co-grafted Axial Skin Flaps in Rats Model. Aesthetic Plastic Surgery. 46(4). 1950–1963.

11.

Liu, Jie, Xiaoling Wei, Junlong Hu, et al.. (2021). Different concentrations of C5a affect human dental pulp mesenchymal stem cells differentiation. BMC Oral Health. 21(1). 470–470. 5 indexed citations

12.

Zhu, Yunpeng, Qing Xue, Minlu Zhang, et al.. (2020). Effect of ticagrelor with or without aspirin on vein graft outcome 1 year after on-pump and off-pump coronary artery bypass grafting. Journal of Thoracic Disease. 12(9). 4915–4923. 4 indexed citations

13.

Zhao, Liang, Baocai Wang, Junjie Sun, et al.. (2020). The circular RNA TLK1 exacerbates myocardial ischemia/reperfusion injury via targeting miR-214/RIPK1 through TNF signaling pathway. Free Radical Biology and Medicine. 155. 69–80. 54 indexed citations

14.

Zhu, Yunpeng, Minlu Zhang, Qing Xue, et al.. (2020). Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 163(3). 1030–1039.e4. 2 indexed citations

15.

Wang, Baocai, et al.. (2020). Human umbilical cord blood–derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biology and Toxicology. 37(1). 51–64. 267 indexed citations breakdown →

16.

Lu, Guoqing, Xianjie Chen, Xiliang Zhu, et al.. (2020). Knockdown of Long Noncoding RNA SNHG14 Protects H9c2 Cells Against Hypoxia-induced Injury by Modulating miR-25-3p/KLF4 Axis in Vitro. Journal of Cardiovascular Pharmacology. 77(3). 334–342. 6 indexed citations

17.

Ge, Zhenwei, Xiliang Zhu, Baocai Wang, et al.. (2019). MicroRNA-26b relieves inflammatory response and myocardial remodeling of mice with myocardial infarction by suppression of MAPK pathway through binding to PTGS2. International Journal of Cardiology. 280. 152–159. 57 indexed citations

18.

Wang, Baocai, et al.. (2019). LncRNA OIP5-AS1 inhibits osteoblast differentiation of valve interstitial cells via miR-137/TWIST11 axis. Biochemical and Biophysical Research Communications. 511(4). 826–832. 24 indexed citations

19.

Cheng, Zhaoyun, Zhenwei Ge, Baocai Wang, et al.. (2018). Clinical efficacy of two different tricuspid annuloplasty techniques in left cardiac valve surgery. Asian Pacific Journal of Tropical Medicine. 11(2). 166–166. 1 indexed citations

20.

Cheng, Zhaoyun, Sheng Wang, Jian Zhao, et al.. (2014). Twelve years' experience and clinical results of using the radial artery for coronary revascularization. Chinese Medical Journal. 127(5). 887–892. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact